Medindia

X

Import and Manufacture of Rosiglitazone Banned

by Kathy Jones on  October 8, 2010 at 9:36 PM Drug News   - G J E 4
Following the ban on rosiglitazone in Europe and the restricted access in the United States, the Indian government has imposed a ban on the import and manufacture of the diabetes drug in the country.
 Import and Manufacture of Rosiglitazone Banned
Import and Manufacture of Rosiglitazone Banned
Advertisement

People using rosiglitazone have experienced a number of serious side effects including cardiovascular events and adverse effects on lipid profile leading to its ban in Europe.

Advertisement
An Expert Committee on October 7 recommended a similar ban in India which was enforced with immediate effect.

The Drugs Controller General of India (DCGI) Dr Surinder Singh revealed that directives have been sent to state drugs controllers in the country regarding the suspension of licenses granted to manufacture for sale and distribution of the drug.




Source:
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All